New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...

Women who stop taking a GLP-1 weight loss/diabetes medication just prior to a pregnancy appear to be at higher odds for excess weight gain and complications while pregnant, new research shows. As the ...

Share on Pinterest New research suggests that stopping GLP-1 drugs before pregnancy is linked to complications like gestational diabetes and preeclampsia. Tatsiana Volkava/Getty Images A recent study ...

Compared with unexposed pregnancies, the GLP-1 RA group had a higher risk for excess gestational weight gain, and a higher risk for preterm delivery, gestational diabetes, and hypertensive disorders ...

You’ve heard of the rise of “Ozempic babies” — where women who’ve previously struggled with infertility get knocked up on GLP-1s — but new research shows that going off those drugs may have a negative ...

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and ...

ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of gestational diabetes but not pre-eclampsia during pregnancy, according to a small ...

In the early 1960s, after studies confirmed that it was linked to congenital disorders in more than 10,000 children, ...